Combined interferon a2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial - Reply by M. Galeazzi, F. Bellisai, A. Crisanti, A. Donvito

Get full text

Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection by M. Galeazzi, F. Bellisai, S. D'Alfonso, G. Morozzi, C. Giannitti

Get full text

Indications for intra-venous immunoglobulin treatment in rheumatic diseases by F. Laghi Pasini, P.L. Capecchi, F. Bellisai, P.E. Lazzerini, M. Galeazzi

Get full text

Chromosome aberrations, valued as frequency of spontaneous micronuclei, in subjects with suspected presclerodermic Raynaud’s phenomenon by G. Porciello, R. Scarpato, F. Storino, F. Cagetti, F. Bellisai, G. Morozzi, R. Marcolongo, L. Migliore, C. Ferri, M. Galeazzi

Get full text

Anti-proteinase 3 antibodies in diffuse systemic sclerosis (SSc) with normotensive renal impairment: is it suggestive for an overlapping between SSc and idiopathic vasculitis? by F. Bellisai, G. Morozzi, M.R. Bacarelli, A. Radice, R.A. Sinico, J. Wieslander, G.D. Sebastiani, V. Campanella, R. Marcolongo, M. Galeazzi

Get full text

PO.6.133 Dynamical trajectory of glucocorticoid tapering and discontinuation in real-world patients with newly diagnosed systemic lupus erythematosus: the gulp study by F Franceschini, M Fredi, F Conti, F Iannone, FR Spinelli, M Govoni, A Doria, M Mosca, L Iaccarino, F Bellisai, A Cauli, C Tani, M Piga, I Prevete, GD Sebastiani, E Chessa, A Floris, L Coladonato, A Bortoluzzi, R D’Alessandro, A Zanetti, G Carrara, CA Scirè